Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Shire International GmbH | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Patients with type 3 intestinal failure are completely reliant on artificial feeding and often manage this at home; home parenteral nutrition (HPN). HPN therapy is life saving for these patients.
The Parenteral Nutrition Impact Questionnaire (PNIQ) is a proven tool for measuring quality of life when receiving HPN.
This study will recruit HPN patients across the United Kingdom (UK) and ask them to complete the PNIQ survey at several different time points. This will assess the impact of HPN over time. Family members involved in the participants HPN care will also be asked to complete a carer burden survey (at one time point) to assess the impact of HPN on carers.
Providing a person with food through a vein is known as parenteral nutrition (PN) or artificial tube feeding. This process is used when nutrients from food can't be taken in by the intestine (intestinal failure). Patients with type 3 intestinal failure are completely reliant on artificial feeding and often manage this at home; home parenteral nutrition (HPN). HPN therapy is life saving for these patients.
It is important to assess patients quality of life and their own reported effects of the HPN. The Parenteral Nutrition Impact Questionnaire (PNIQ) is a proven tool for measuring quality of life when receiving HPN.
A recent study involving the use of the PNIQ in multiple hospitals in the UK, showed that those on fewer nights of HPN had better quality of life than those on more nights of HPN. Whilst this was useful for looking at quality of life at one time point, it is now important to assess change in quality life over time and any impact on family members quality of life.
This study will recruit HPN patients across the UK and ask them to complete the PNIQ survey at several different time points. This will assess the impact of HPN over time. Family members involved in the participants HPN care will also be asked to complete a carer burden survey (at one time point) to assess the impact of HPN on carers.
The study is being funded by Shire Pharmaceuticals Ltd.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patient | Patients who are receiving Home Parenteral Support (HPN) (artificially fed through a vein) due to intestinal failure |
| |
| Carer | Family member or carer of patient who is receiving Home Parenteral Support |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Parenteral nutrition | Procedure | Impact of parenteral nutrition on patient quality of life over time and impact on carer burden |
|
| Measure | Description | Time Frame |
|---|---|---|
| Patient reported outcomes | Change in Patient reported outcomes (PNIQ score) in people receiving HPN. Score from 0-20, with 0 being high Quality of life and 20 being low quality of life. | Baseline, five, 10 and 15 months post entry |
| Measure | Description | Time Frame |
|---|---|---|
| Carer burden | Caregiver burden (carer burden survey) in family members/close friends providing HPN healthcare to a patient receiving HPN. Score from 0-84, with 0 being no symptoms and 84 being very severe symptoms | Baseline |
| Length of time receiving HPN |
Not provided
Inclusion Criteria:
Patients:
Carers:
Exclusion Criteria:
Patients:
Carers:
• Family members not directly involved with caring for participants
Not provided
Not provided
Not provided
Approximately 1400 eligible participants from at least 15 NHS sites who are receiving HPN will be invited to participate. Close family relatives or friends who are carers for the eligible participants will also be invited to participate.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Manchester | Manchester | United Kingdom |
Not provided
| Label | URL |
|---|---|
| Institute research project page | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | Aug 6, 2025 | |
| Reset | Aug 22, 2025 |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Dec 16, 2019 | Jan 13, 2020 | Prot_SAP_000.pdf |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Aug 6, 2025 | Aug 22, 2025 |
| ID | Term |
|---|---|
| D006963 | Hyperphagia |
| D000090124 | Intestinal Failure |
| ID | Term |
|---|---|
| D012817 | Signs and Symptoms, Digestive |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D007410 | Intestinal Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D010288 | Parenteral Nutrition |
| D016331 | Parenteral Nutrition, Home |
| ID | Term |
|---|---|
| D005248 | Feeding Methods |
| D013812 | Therapeutics |
| D018529 | Nutritional Support |
| D044623 | Nutrition Therapy |
Not provided
Not provided
Not provided
Not provided
Not provided
Amount of time the patient has been receiving HPN (months/years) |
| Baseline, five, 10 and 15 months post entry |
| Change in number of weekly HPN infusions | How often the patient is connected to an infusion each week (numerical) | Baseline, five, 10 and 15 months post entry |
| Change in number of hours connected to HPN infusions each night | How many hours the patient is connected to an infusion each night (hours) | Baseline, five, 10 and 15 months post entry |
| D005767 | Gastrointestinal Diseases |
| D004066 | Digestive System Diseases |
| D006699 |
| Home Care Services |
| D003153 | Community Health Services |
| D006296 | Health Services |
| D005159 | Health Care Facilities Workforce and Services |